Characterized by elevated intracranial pressure (ICP) and symptoms like persistent headaches, visual changes, and pulsatile tinnitus, IIH mostly affects women of childbearing age who are ...

Patients with idiopathic intracranial hypertension who use a GLP-1 receptor agonist are less likely to experience symptoms, require medications, or undergo surgery.

For patients with idiopathic intracranial hypertension, GLP-1 RA treatment is linked to improved clinical outcomes compared with conventional therapies.

Johns Hopkins Medicine researchers have published new research that reports on a potential alternative and less-invasive approach to measure intracranial pressure (ICP) in patients.

Brain tumour is often not about collapsing or intense pain, it’s about the simple signs that sneak into daily life. From dull ...

A small trial found that taking the GPL-1 medication liraglutide reduced headache frequency in people with obesity.

Importantly, no patients discontinued treatment due to side effects, and these symptoms resolved spontaneously ... potentially through mechanisms related to intracranial pressure regulation and CGRP ...

After surgery, some patients have a transient or permanent increase in intracranial pressure, including idiopathic intracranial hypertension. 44 In patients with persistent or recurrent symptoms ...

A technology developed by the Brazilian company brain4care has been shown to be able to measure absolute values of intracranial pressure (ICP) more accurately than existing non-invasive methods.